The STEP 1 trial revealed a mean weight loss of 14.9% over 68 weeks in non-diabetic participants
Pourcet, B
For health system leaders, clinicians, and Medicare administrators, the announcement raises important questions about access, pricing stability, and the future role of telehealth in obesity care
Other strategies have involved producing formulations with increased binding to albumin through a fatty acid linker [14]
Individual results vary significantly, and these numbers come from supervised clinical settings with lifestyle counseling
Conservatively, GLP-1 medications are already removing over $3.3 billion a year from the Canadian food economymostly from snacks, baked goods, sugary beverages, and alcohol